Norris Medicines appoints new CFO and Key Managerial Personnel

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹14.82

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-1.6% vs market

Trading & Distributors peers, median of 128sector+0.9%-1.4% vs sector

On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 1.4 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5+1.1-1.6+0.9-1.4

Next day

-4.6+2.4-7.0+1.1-5.7

-7.2+2.9-10.1+1.5-8.7

-6.2+4.2-10.4+1.2-7.4

-0.7+4.6-5.3+2.4-3.1

-0.1+4.6-4.7+2.2-2.4

+8.0+4.4+3.6+1.8+6.2

15d

+5.3+5.7-0.5+0.3+4.9

+1.2+6.6-5.3+0.4+0.8

+15.7+5.4+10.3-1.9+17.7

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 128Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board of Norris Medicines approved the appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer and Key Managerial Personnel effective July 30, 2026. Patel has been with the company for over 11 years with experience in finance, accounts, taxation, budgeting, and corporate management. He is not related to any existing directors or KMP.

Likely market impact

Internal elevation to CFO brings continuity to finance leadership. Routine governance update, no immediate price impact expected.